Explore the Potential with AI-Driven Innovation
The focused library is created on demand with the latest virtual screening and parameter assessment technology, supported by the Receptor.AI drug discovery platform. This method is more effective than traditional methods and results in higher-quality compounds with better activity, selectivity, and safety.
We carefully select specific compounds from a vast collection of over 60 billion molecules in virtual chemical space. Our partner Reaxense helps in synthesizing and delivering these compounds.
The library includes a list of the most promising modulators annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Also, each compound is presented with its optimal docking poses, affinity scores, and activity scores, providing a comprehensive overview.
We employ our advanced, specialised process to create targeted libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
It includes comprehensive molecular simulations of the catalytic and allosteric binding pockets and the ensemble virtual screening accounting for their conformational mobility. In the case of designing modulators, the structural changes induced by reaction intermediates are taken into account to leverage activity and selectivity.
Our library is unique due to several crucial aspects:
partner
Reaxense
upacc
O95147
UPID:
DUS14_HUMAN
Alternative names:
MKP-1-like protein tyrosine phosphatase; Mitogen-activated protein kinase phosphatase 6
Alternative UPACC:
O95147
Background:
Dual specificity protein phosphatase 14 (DUSP14), also known as MKP-1-like protein tyrosine phosphatase and Mitogen-activated protein kinase phosphatase 6, plays a crucial role in cellular processes by inactivating MAP kinases. It dephosphorylates key MAP kinases including ERK, JNK, and p38, and negatively regulates TCR signaling through the dephosphorylation of MAP3K7 adapter TAB1.
Therapeutic significance:
Understanding the role of Dual specificity protein phosphatase 14 could open doors to potential therapeutic strategies.